Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome

Launched by POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH · Nov 5, 2021

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how blood clotting works in patients with conditions like portal vein thrombosis (PVT) and Budd-Chiari syndrome (BCS). These conditions can cause blockages in the blood vessels of the liver, leading to serious health issues. The researchers are particularly interested in using advanced tests that provide more detailed information about blood clotting compared to standard tests. They hope that by learning more about these conditions, they can improve treatment options and outcomes for patients.

To participate in this study, individuals must be between 18 and 65 years old and have a confirmed diagnosis of portal vein thrombosis through imaging tests. Those who are pregnant, recently had blood transfusions, or have certain serious health conditions may not be eligible. Participants can expect to undergo some screening tests and receive close monitoring throughout the trial. This research is important because it aims to enhance our understanding of blood clotting disorders, which could lead to better treatments for people with liver-related issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Gender: Either gender
• • Age:18 - 65 years of age
• • Patient with portal vein thrombosis documented on imaging (USG with color doppler, CECT abdomen and CEMRI abdomen
• Exclusion Criteria:
• • Patients who do not consent to the study.
• • Patient with pregnancy and lactation
• • Patients with a history of blood transfusions in the last two weeks
• • Patients who are too sick to undergo screening tests.
• • Patients on hemodialysis
• • Chronic heart failure and chronic pulmonary or end-stage renal disease
• • Patients who are on plasma therapy